2011
DOI: 10.1586/ers.11.62
|View full text |Cite
|
Sign up to set email alerts
|

Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
108
0
12

Year Published

2013
2013
2018
2018

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 134 publications
(122 citation statements)
references
References 92 publications
2
108
0
12
Order By: Relevance
“…In the literature, some cohorts have a very high prevalence of hypertension (63.4%), 19 whereas others, including ours (42%), are within the 40% to 60% range. [20][21][22] Our congestive heart failure estimate 15 ; similarly, we found cohort members with a "COPDother" comorbidity (490.x, bronchitis, not specifi ed as acute or chronic), at less risk of subsequent hospital admission. Interestingly, "substance-related disorders" comorbidity, although present in only a small percentage (1.5%, 512 of 33,799) of the cohort, had the largest association with increased subsequent hospital admission among the comorbidities we examined.…”
Section: Comorbiditiessupporting
confidence: 60%
“…In the literature, some cohorts have a very high prevalence of hypertension (63.4%), 19 whereas others, including ours (42%), are within the 40% to 60% range. [20][21][22] Our congestive heart failure estimate 15 ; similarly, we found cohort members with a "COPDother" comorbidity (490.x, bronchitis, not specifi ed as acute or chronic), at less risk of subsequent hospital admission. Interestingly, "substance-related disorders" comorbidity, although present in only a small percentage (1.5%, 512 of 33,799) of the cohort, had the largest association with increased subsequent hospital admission among the comorbidities we examined.…”
Section: Comorbiditiessupporting
confidence: 60%
“…Furthermore, COPD patients with CVD, hypertension and T2DM were shown to be at increased risk for hospitalizations and all-cause mortality (4). The high MetS prevalence in lower disease stages coincides with the reported high cardiovascular-related mortality in mild to moderate disease (5). Furthermore, recent studies have identified a so called "co-morbidity predominant subtype" of COPD patients, which is characterized by a cluster of metabolic co-morbidities, including obesity, CVD and T2DM (43,44).…”
Section: Discussionmentioning
confidence: 57%
“…Previous research has indeed shown that both CVD and T2DM are frequent comorbidities in COPD (4,5). Furthermore, COPD patients with CVD, hypertension and T2DM were shown to be at increased risk for hospitalizations and all-cause mortality (4).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Примерно по тем же причинам мы отметили боль-шую частоту ХОБЛ у больных с ИМ (р<0,0001). Исходная гипоксия организма, которая встречается у всех больных при нарушении дыхательной функции легких, приводит к функционированию порочного круга: гипоксия -повы-шение сердечного выброса для компенсации тканевого газообмена -возрастание нагрузки на миокард -ише-мия миокарда -усиление гипоксии [3,10]. Стоит отме-тить, что гипертрофия миокарда встречается у 90% боль-ных со стабильным течением ХОБЛ [12].…”
Section: результаты и обсуждениеunclassified